Autopsy report · NCT05255770

A Clinical Investigation to Assess the Effectiveness of Benzocaine Condoms in Healthy Adult Men

“Change of the product development strategy”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Reckitt Benckiser Healthcare (UK) Limited

Sponsor type

Industry

Conditions

Ejaculation Delayed

Interventions

Test condom A (NRL condom with 5% benzocaine paste); Test condom B (NRL condom with 3% benzocaine paste); Control NRL condom

Participants

0

Trials that died the same way

• Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
  “Company development strategy change” (83% match in meaning)
• A Study of EMB-02 in Participants With Advanced Solid Tumors
  “Company's resource optimization and product's development change” (76% match in meaning)
• A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosus
  “Company development strategy adjustment” (74% match in meaning)
• A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
  “Alternate development strategy” (72% match in meaning)
• ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)
  “Business strategy change” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.